Skip to content

Khaled Alabdallah

NPI 1356832893ActiveIndividual· Internal Medicine, Cardiovascular Disease· Galveston, TX

Internal Medicine, Cardiovascular Disease in Galveston, Texas, licensed in TX, with an NPI issued in May 2018. Part D covered 437 prescriptions written in 2024, 70% of them generic. Abbott Laboratories was the largest of 9 companies reporting payments in 2025, $7,505 in all, mostly travel and lodging.

Overview

NPI1356832893
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedMay 21, 2018
Last updated in NPPESJun 29, 2023
Certified by providerJun 29, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000XU4454TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)437 · 828 30-day fills
Patients90
Total drug cost$292,675
Generic share70% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$7,505 · 69 payments from 9 companies
  • 2024$2,530 · 26 payments from 8 companies

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$2,38322
Biotronik Inc.$1,9263
Biosense Webster, Inc.$1,71114
Abiomed$559.927
Boston Scientific Corporation$507.1518

What the 2025 payments were for

  • Travel and Lodging$4,242 · 11 payments
  • Food and Beverage$3,262 · 58 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Galveston

All Internal Medicine, Cardiovascular Disease providers in Texas →